{'fraction_non_alphanumeric': 0.03352891869237217, 'fraction_numerical': 0.005029337803855826, 'mean_word_length': 5.707865168539326, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Prognostic Value of Geriatric Screening Tools in Elderly Cancer Patients].

The elderly population is heterogeneous. Chronological age alone does not reflect heterogeneity in the aging process. It is recommended that elderly cancer patients should be evaluated for some form of geriatric assessment(GA)to detect problems, to predict treatment-related toxicities, to predict functional decline, to predict prognosis, and to assist in cancer treatment decisions. It was reported that functional status, nutritional status, mental status, polypharmacy, and comorbidity were independent prognostic factors for survival in elderly cancer patients. Although a full GA is valuable, it is time-consuming. Therefore, in a busy practice, geriatric screening tools are useful to identify patients in need of further evaluation using a full GA. Assessment for screening tools takes a few minutes. Some screening tools such as Geriatric 8(G8), Vulnerable Elders Survey-13(VES-13), Groningen Frailty Indicator(GFI), and Flemish version of the Triage Risk Screening Tool(fTRST)have prognostic value for survival. These screening tools may help physicians make informed treatment decisions in daily practice.